Emtricitabine and tenofovir
Generic name: Emtricitabine And Tenofovir
Dosage form: oral tablet (100 mg-150 mg; 120 mg-15 mg; 133 mg-200 mg; 167 mg-250 mg; 200 mg-25 mg; 200 mg-300 mg)
Drug class:
Antiviral combinations
Usage of Emtricitabine and tenofovir
Emtricitabine and Tenofovir is an antiviral combination medicine that is used together with other HIV medications in adults and children to treat HIV (human immunodeficiency virus). HIV can cause acquired immunodeficiency syndrome (AIDS). Emtricitabine and tenofovir is not a cure for HIV or AIDS.
Emtricitabine and tenofovir is also used as pre-exposure prophylaxis (PrEP) in adults and teenagers to reduce the risk of HIV infection.
There is more than one emtricitabine and tenofovir brand form available. Your doctor will determine which brand form is the right treatment for you based on weight, age, and other factors.
Emtricitabine and tenofovir may also be used for purposes not listed in this medication guide.
Emtricitabine and tenofovir side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Emtricitabine and tenofovir can affect your immune system (even weeks or months after you've used emtricitabine and tenofovir). Tell your doctor if you have:
Mild symptoms of lactic acidosis may worsen over time, and this condition can be fatal. Get emergency medical help if you have: unusual muscle pain, trouble breathing, stomach pain, vomiting, fast/slow or irregular heartbeats, dizziness, feeling cold, or feeling very weak or tired.
Also call your doctor at once if you have:
Common side effects of emtricitabine and tenofovir may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Emtricitabine and tenofovir
Do not use emtricitabine and tenofovir for PrEP if you are HIV-positive or have not cOnfirmed you are HIV-negative.
Tell your doctor if you have or have ever had:
You may develop lactic acidosis, a dangerous build-up of lactic acid in your blood. Ask your doctor about your risk.
Tell your doctor if you are pregnant or plan to become pregnant. To prevent HIV in a newborn baby, use all medications to control your infection during pregnancy. Your name may be listed on an antiviral pregnancy registry.
Women with HIV should not breastfeed. The virus can pass to your baby in your breast milk.
Relate drugs
- AccessPak for HIV PEP Basic
- AccessPak for HIV PEP Expanded with Kaletra
- AccessPak for HIV PEP Expanded with Viracept
- Atazanavir and cobicistat
- Atripla
- Cobicistat and darunavir
- Cobicistat, darunavir, emtricitabine, and tenofovir
- Cobicistat, elvitegravir, emtricitabine, and tenofovir
- Combivir
- Complera
- Abacavir and lamivudine
- Abacavir, dolutegravir, and lamivudine
- Abacavir, lamivudine, and zidovudine
- Bictegravir, emtricitabine, and tenofovir
- Bictegravir, emtricitabine, and tenofovir alafenamide
- Biktarvy
- Cabenuva
- Cabotegravir and rilpivirine
- Casirivimab and imdevimab
- Cilgavimab and tixagevimab
- Cimduo
- Darunavir and cobicistat
- Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide
- Dasabuvir, ombitasvir, paritaprevir, and ritonavir
- Delstrigo
- Descovy
- Descovy Blister Pack
- Dolutegravir and lamivudine
- Dolutegravir and rilpivirine
- Doravirine, lamivudine, and tenofovir
- Dovato
- Efavirenz, emtricitabine, and tenofovir
- Efavirenz, lamivudine, and tenofovir
- Elbasvir and grazoprevir
- Elvitegravir, cobicistat, emtricitabine, and tenofovir
- Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
- Emtricitabine and tenofovir
- Emtricitabine and tenofovir alafenamide
- Emtricitabine, lopinavir, ritonavir, and tenofovir
- Emtricitabine, nelfinavir, and tenofovir
- Emtricitabine, rilpivirine, and tenofovir
- Emtricitabine, rilpivirine, and tenofovir alafenamide
- Epclusa
- Epzicom
- Evotaz
- Evusheld
- Genvoya
- Glecaprevir and pibrentasvir
- Harvoni
- Juluca
- Lamivudine and tenofovir
- Lamivudine and zidovudine
- Ledipasvir and sofosbuvir
- Mavyret
- Nirmatrelvir and ritonavir
- Odefsey
- Ombitasvir, paritaprevir, and ritonavir
- Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Paxlovid
- Prezcobix
- Regen-Cov
- Sofosbuvir and Velpatasvir
- Sofosbuvir, velpatasvir, and voxilaprevir
- Stribild
- Symfi
- Symfi Lo
- Symtuza
- Technivie
- Temixys
- Triumeq
- Triumeq PD
- Trizivir
- Truvada
- Viekira
- Viekira Pak
- Viekira XR
- Vosevi
- Zepatier
How to use Emtricitabine and tenofovir
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Emtricitabine and tenofovir is taken once per day. You may take this medicine with or without food.
If you are on dialysis, take this medicine after dialysis.
Use all HIV medications as directed. Do not change your dose, skip doses or stop using a medicine without your doctor's advice. Remain under the care of a doctor.
Your dose needs may change if you switch to a different brand, strength, or form of this medicine. Avoid medication errors by using exactly as directed on the label, or as prescribed by your doctor.
Emtricitabine and tenofovir (PrEP) alone will not protect you from infection with HIV. You must also use safer sex practices and get tested for HIV before starting prophylaxis and at least once every 3 months.
If you've had hepatitis B, it may come back or get worse after you stop using this medicine. You may need frequent blood tests to check your liver function and other medical tests before starting this medicine and for several months after you stop.
You will also need medical tests and your kidney function to be checked often while using this medicine.
Doses are based on weight. Your dose may change if you gain or lose weight.
Store tightly closed in the original container at room temperature, away from moisture and heat.
Warnings
If you've ever had hepatitis B, it may become active or get worse after you stop using this medicine. You may need frequent blood tests to check your liver function and other medical tests before starting this medicine and for several months after you stop.
Emtricitabine and tenofovir pre-exposure prophylaxis (PrEP) is used to reduce the risk of becoming infected with HIV. Do not use emtricitabine and tenofovir for PrEP if you are HIV-positive or have not confirmed you are HIV-negative.
What other drugs will affect Emtricitabine and tenofovir
Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.
Emtricitabine and tenofovir can harm your kidneys, especially if you also use certain medicines for infections, cancer, osteoporosis, organ transplant rejection, high blood pressure, or pain or arthritis (including Advil, Motrin, and Aleve).
Tell your doctor about all your other medicines, especially:
This list is not complete and many other drugs may affect emtricitabine and tenofovir. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions